대한핵의학회지 (1967년~2009년)
Nucl Med Mol Imaging 2008;42(Suppl)52~59
대장-직장 및 항문암에서 F-18 FDG PET (PET/CT)의 임상 이용
(Clinical Application of F-18 FDG PET (PET/CT) in Colo-rectal and Anal Cancer)
Author 김병일,
Byung Il Kim
Affiliation 한국원자력의학원 원자력병원 핵의학과
Department of Nuclear Medicine, Korea Institute of Radiological & Medical Sciences, Seoul, Korea
Abstract

In the management of colo-retal and anal cancer, accurate staging, treatment evaluation, early detection of recurrence are main clinical problems. F-18 FDG PET (PET/CT) has been reported as useful in the management of colo-rectal and anal cancer because that PET has high diagnostic performance comparing to conventional studies. In case of liver metastases, for confirmation of no extrahepatic metastases, in case of high risk of metastasis, for avoiding unnecessary operation, PET (PET/CT) is expected more useful. In anal cancer, PET is expected useful in lymph node staging. For the early prediction of chemotherapy or radiation therapy effect PET has been reported as useful, also. In early detection of recurrence by PET, cost-benefit advantages has been suggested, also. PET/CT is expected to have higher diagnostic performance than PET alone. (Nucl Med Mol Imaging 2008;42(suppl 1):52-59)

Keyword Colo-rectal, Anal, F-18 FDG, PET, PET/CT
Full text Article 42s9.pdf 42s9.pdf
(03121)서울시 종로구 지봉로 29 금호팔레스빌딩 1705호
TEL : 02-745-2040 FAX : 02-745-3833 E-mail : ksnm@ksnm.or.kr
Copyright 2012 by The Korean Society of Nuclear Medicine(KSNM)